Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 155.75 billion. The enterprise value is 202.54 billion.

Market Cap	155.75B
Enterprise Value	202.54B

Important Dates

The last earnings date was Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Feb 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.56%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	535.85M

Valuation Ratios

The trailing PE ratio is 39.42.

PE Ratio	39.42
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.78, with an EV/FCF ratio of 20.17.

EV / Earnings	51.27
EV / Sales	6.33
EV / EBITDA	13.78
EV / EBIT	21.88
EV / FCF	20.17

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 10.36.

Current Ratio	1.26
Quick Ratio	0.84
Debt / Equity	10.36
Debt / EBITDA	3.96
Debt / FCF	5.86
Interest Coverage	2.64

Financial Efficiency

Return on equity (ROE) is 67.55% and return on invested capital (ROIC) is 8.74%.

Return on Equity (ROE)	67.55%
Return on Assets (ROA)	6.40%
Return on Invested Capital (ROIC)	8.74%
Return on Capital Employed (ROCE)	14.08%
Revenue Per Employee	1.15M
Profits Per Employee	141,090
Employee Count	28,000
Asset Turnover	0.35
Inventory Turnover	1.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.91% in the last 52 weeks. The beta is 0.56, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+9.91%
50-Day Moving Average	266.56
200-Day Moving Average	284.57
Relative Strength Index (RSI)	66.44
Average Volume (20 Days)	483

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.42

Income Statement

In the last 12 months, Amgen had revenue of EUR 32.28 billion and earned 3.95 billion in profits. Earnings per share was 7.30.

Revenue	32.28B
Gross Profit	22.18B
Operating Income	9.35B
Pretax Income	4.45B
Net Income	3.95B
EBITDA	14.64B
EBIT	9.35B
Earnings Per Share (EPS)	7.30

Full Income Statement

Balance Sheet

The company has 11.56 billion in cash and 58.80 billion in debt, giving a net cash position of -47.24 billion.

Cash & Cash Equivalents	11.56B
Total Debt	58.80B
Net Cash	-47.24B
Net Cash Per Share	n/a
Equity (Book Value)	5.68B
Book Value Per Share	10.57
Working Capital	5.73B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.10 billion and capital expenditures -1.06 billion, giving a free cash flow of 10.04 billion.

Operating Cash Flow	11.10B
Capital Expenditures	-1.06B
Free Cash Flow	10.04B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.71%, with operating and profit margins of 28.95% and 12.24%.

Gross Margin	68.71%
Operating Margin	28.95%
Pretax Margin	13.79%
Profit Margin	12.24%
EBITDA Margin	45.35%
EBIT Margin	28.95%
FCF Margin	31.10%

Dividends & Yields

This stock pays an annual dividend of 8.53, which amounts to a dividend yield of 2.96%.

Dividend Per Share	8.53
Dividend Yield	2.96%
Dividend Growth (YoY)	7.00%
Years of Dividend Growth	12
Payout Ratio	118.14%
Buyback Yield	-0.56%
Shareholder Yield	2.41%
Earnings Yield	2.54%
FCF Yield	6.45%

Dividend Details

Stock Splits

The last stock split was on November 22, 1999. It was a forward split with a ratio of 2.

Last Split Date	Nov 22, 1999
Split Type	Forward
Split Ratio	2

Scores

Amgen has an Altman Z-Score of 1.5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.5
Piotroski F-Score	n/a